Table 2

Unit costs of consequential TB and HIV care, 2019 US$

Activities	Description	Unit	Unit cost	Source
ART cost	Drugs and clinic visits	Per patient month	60.22	MATCH study37
TB testing	Sum of costs of first- and second-line diagnostic tests, including visits and antibiotics	Per test	51.08	Unpublished data from XTEND trial, as calculated by Bozzani et al.35
TB diagnosis	One clinic visit to collect results	Per person diagnosed	5.77	Unpublished data from XTEND trial
DS-TB treatment	Facility-based observation. 2 months intensive phase, 4 months continuation phase	Per patient month	23.33	Drug prices from the Stop TB Partnership’s Global Drug Facility.38 Facility visit costs from Sinanovic et al (2015),39 assuming only 20% of patients are treated under DOTS, while remaining patients collect drugs from clinic once a month
MDR-TB treatment	6 months intensive phase, 12 months continuation phase	Per patient month	456.98	As for DS-TB treatment, assuming 40% of patients are hospitalised during intensive phase, the rest receive fully decentralised treatment.39
Short-course MDR-TB treatment	5 months intensive phase, 5 months continuation phase	Per patient month	411.94	As for DS-TB treatment. 70% of newly diagnosed MDR-TB patients assumed to be eligible for short-course treatment

.ART, antiretroviral therapy; DOTS, directly observed treatment, short-course; DS-TB, drug-susceptible TB; MDR-TB, multidrug-resistant TB; TB, tuberculosis.